OREANDA-NEWS. Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has enhanced its strength in image-guided therapy innovation with the establishment of a new in-house simulation facility for early and continuous product design validation and end-user testing. The new facility is located at Philips’ existing R&D and manufacturing facility in Best, the Netherlands.

“We have combined our expertise and activities in the field of product design validation and usability testing, and expanded the team, enabling us to validate and test throughout the product creation process from early development to final product,” said Bert van Meurs, General Manager, Philips Image Guided Therapy. “Our goal is to further enhance the user experience and enable the effective and efficient use of our technology - for example during critical procedures such as the minimally-invasive treatment of a heart attack or stroke.”

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.